Covered recipient · General Payments record
ALISON KANG
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2019–2024
$1,732.90
- Reported across 56 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $273.95 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | $138.51 | 5 |
| ABBVIE INC. | $82.61 | 4 |
| ORGANOGENESIS INC. | $32.43 | 1 |
| Galderma Laboratories, L.P. | $20.40 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.79 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104027177 | CMS |
| ABBVIE INC. | $13.46 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104027179 | CMS |
| ABBVIE INC. | $22.72 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104027181 | CMS |
| ABBVIE INC. | $30.64 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104027183 | CMS |
| Galderma Laboratories, L.P. | $20.40 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145307433 | CMS |
| Organogenesis Inc. | $32.43 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145433448 | CMS |
| REVANCE THERAPEUTICS, INC. | $5.05 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147921384 | CMS |
| REVANCE THERAPEUTICS, INC. | $51.50 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147921386 | CMS |
| REVANCE THERAPEUTICS, INC. | $41.17 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147921388 | CMS |
| REVANCE THERAPEUTICS, INC. | $17.58 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147921390 | CMS |
| REVANCE THERAPEUTICS, INC. | $23.21 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147921392 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.